Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors. - Wikidata - wikimedia - TriplyDB

Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors.

Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors.

http://www.wikidata.org/entity/Q34416049

about

Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice DNA methylation changes in epithelial ovarian cancer histotypes.Cell-free DNA as a diagnostic marker for cancer: current insights Methylation of cell-free circulating DNA in the diagnosis of cancer Lung cancer epigenetics: emerging biomarkers Peripheral blood DNA methylation profiles are indicative of head and neck squamous cell carcinoma: an epigenome-wide association study Leukocyte-adjusted epigenome-wide association studies of blood from solid tumor patients RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.CGPredictor: a systematic integrated analytic tool for mining and examining genome-scale cancer independent prognostic epigenetic marker panels Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers, ovarian, endometrial and obstetric disorders and fetal aneuploidy.The MethDet: a technology for biomarker development Genome-wide DNA methylation profiling of cell-free serum DNA in esophageal adenocarcinoma and Barrett esophagus.DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma.Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.Methylated DNA and microRNA in body fluids as biomarkers for cancer detection.Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer.DNA methylation as clinically useful biomarkers-light at the end of the tunnel Liquid Biopsies for Cancer: Coming to a Patient near You.CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA.Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future.Towards DNA methylation detection using biosensors.Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma.The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.Molecular biomarkers in 2013.Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.Analysis of RTEL1 and PCDHGB6 promoter methylation in circulating-free DNA of lung cancer patients using liquid biopsy: A pilot study.Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.Review article: Novel technologies in the treatment and monitoring of advanced and relapsed epithelial ovarian cancer.

P2860

Q26740622-EFCCDA65-8F53-4CEC-A63B-B90498BA6138 Q27690722-18AF183F-37C2-4935-A3B8-A301B939921E Q28074556-B29C6C25-6DE6-4BC8-833A-CE41B13FAAA7 Q28085699-28017CAA-105C-4111-8116-9799A8F0F33B Q28285049-869BCF30-1B16-4BFB-BFE4-805EC9F43BEC Q28383789-0E2C0E52-65D8-446B-82C6-1F97328EB2DE Q28388342-947280F6-C4D9-443D-8F37-81A1BBDDF024 Q33591552-7D64B51A-5A58-4A13-B647-B300533872F0 Q33642944-25FEAF52-91AC-453A-830B-94B00BC9E8F0 Q34426839-FC49C982-B4A0-46FE-ACD2-A9F2BC9099D3 Q35597591-8093F64F-0948-4CC9-9EEF-53228037112C Q35763885-36AC7D85-9691-435E-A781-D324B7D9456A Q35785652-711BCD97-D7FE-4140-AB6C-42FA9FD09848 Q36197208-AAB09FB8-193C-4CA6-86A8-634F4969A8F0 Q36396570-CE6F861A-CF81-4767-8032-62540C706F47 Q36443927-519F08AA-83AF-421F-9FB5-3D73C14F2396 Q36646536-661F2E2E-B915-4C98-816F-9ABC54193408 Q36913739-A2EDAEC6-833E-4D34-80A3-EBF3642657D0 Q37000936-84A3280B-12E2-46CE-B100-F248D0A18F11 Q37148677-6A868EE2-B972-4EBF-AF4A-2665B1E75E89 Q37628173-C2A660A4-DCE8-4EB6-92BD-C62DB52004BB Q37719554-F0E05735-7211-4E94-B982-01060D063821 Q38239831-205B35C9-BD7F-41F5-A97B-2045AABE273E Q38972400-E5CA42E3-5242-4B97-B1FB-0079CBD5CE1F Q41006936-17B3B210-D51A-4081-9F6A-B53D3E064A7E Q42643973-5A32B80F-C42A-4A45-AD11-525253B69194 Q43533587-5AB0415D-8146-415B-9F23-5A9FEB5156F4 Q51134087-D0FD9C3A-45BB-4133-AE61-425BCEA2968B Q51477838-7EB732D2-CD96-4DB5-854B-9732C265BEDA Q52941950-D4556A57-DA0C-4864-9406-611588DD79E4 Q53602004-93161D20-51B5-4E37-90E4-AE49E11A2E16

P2860

Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors.

http://www.wikidata.org/entity/Q34416049

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@ast

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@en

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@nl

type

label

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@ast

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@en

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@nl

prefLabel

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@ast

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@en

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@nl

P1433

Q34416049-35D12295-6625-42D5-A01B-EC190B8F0AE4

P1476

Q34416049-6394327C-E829-44D9-8895-3175D474417F

P2093

Q34416049-2612A71D-BE17-418F-ACFA-8DE0EC47CF68

Q34416049-2B04234B-6B5F-47A3-9DFD-6960887D7B20

Q34416049-4900CB6E-631F-4190-AE4B-D3E02DEFD496

Q34416049-879BADE8-6DF2-4A1E-9DB6-E7FD13FD3BC2

Q34416049-93EC9D66-4A85-448B-883A-1C544368B93F

Q34416049-A8FD7DE8-989D-4EC5-BD7E-55CC2F55D42B

Q34416049-DCA8551F-06CC-4648-A926-0811B31E9CA8

Q34416049-E4AE64F4-03AB-4C67-AFAC-8A63B214B286

Q34416049-EDE0B7EC-CBBE-46AC-BCD8-1338DA7CE645

P2860

Q34416049-019D0E86-6CCA-4E22-913D-CA2F7681C70C

Q34416049-02F72E32-363B-43B4-AE3F-D8619F313DB9

Q34416049-0E06A0B4-6C12-4E10-8439-C2E3BF0E1B29

Q34416049-184DDB7F-3128-4064-B950-3E46A40AC4F6

Q34416049-26498B9A-8B48-465F-BF76-915A97449834

Q34416049-2EC28FD8-7ED1-43E1-94C7-B6CF4759CB02

Q34416049-317D9F21-454C-4E93-9846-A9532B63CD41

Q34416049-3542DD82-88EB-4E50-B4AA-F8E01A3856FE

Q34416049-38C4377F-60EB-4679-BE32-3EA3E7D5BB9B

Q34416049-393F8DE9-2644-4B4C-8E4F-5E9246542D58

P304

Q34416049-186A1993-A9AE-4E96-A72A-F24224F71E8D

P31

Q34416049-7955D9AC-B125-4485-9F41-DCC423B4BC0E

P356

Q34416049-6EB40EE8-B0AC-4986-A1B3-33D3C80E0B2D

P407

Q34416049-68C3E86A-CCB4-4F3D-969A-07B1F00A19E2

P433

Q34416049-1D85A5FF-8453-4BCA-9170-EC3274C4B372

P478

Q34416049-5654FAE8-08D9-4C81-A8D3-93E5C4C9EC32

P577

Q34416049-25650EF6-A9FC-41B7-873B-17C24B114E1F

P5875

Q34416049-E0BF67E9-BDFB-4A83-A566-7E4EA076E4C5

P698

Q34416049-BCF9C4A1-E210-490B-BA81-850FC2B83CCF

P921

Q34416049-0B06FE18-D375-4234-A7AE-076844070605

P932

Q34416049-7B8357C1-CFB6-41A2-A106-BFD97DB6900F

P356

J.YGYNO.2010.09.019

P1433

Gynecologic Oncology

P1476

Distinctive DNA methylation pa ...... with malignant ovarian tumors.

@en

P2093

Anatoliy Melnikov

http://www.w3.org/2001/XMLSchema#string

Anil K Sood

http://www.w3.org/2001/XMLSchema#string

Aparna Kamat

http://www.w3.org/2001/XMLSchema#string

Charles Replogle

http://www.w3.org/2001/XMLSchema#string

Jacob Rotmensch

http://www.w3.org/2001/XMLSchema#string

Qilong Yi

http://www.w3.org/2001/XMLSchema#string

Thomas E Liggett

http://www.w3.org/2001/XMLSchema#string

Victor Levenson

http://www.w3.org/2001/XMLSchema#string

Wei Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha

The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex

BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian

A 2.5-Mb transcript map of a tumor-suppressing subchromosomal transferable fragment from 11p15.5, and isolation and sequence analysis of three novel genes

Cancer statistics, 2009

Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis.

BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer.

Array-based multiplex analysis of DNA methylation in breast cancer tissues.

New tumor markers: CA125 and beyond.

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2010.09.019

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47700830

http://www.w3.org/2001/XMLSchema#string

P698

21056906

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

3004216

http://www.w3.org/2001/XMLSchema#string